Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May guide hERG-aware drug design to limit arrhythmia risk; leaves open prospective clinical validation of reviewed SAR.
Pearlstein et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: